Video Experimental Relacionado
Updated: May 3, 2026

07:00
Dual Effects of Melanoma Cell-derived Factors on Bone Marrow Adipocytes Differentiation
Published on: August 23, 2018
5.2K
Oligosacáridos ligados a lípidos anormales en los linfomas mutantes Thy-1-negativos de clase E
Cell
|July 1, 1979
Resumen
Los linfomas mutantes Thy-1 exhiben un defecto de glicosilación debido a la síntesis bloqueada del precursor de oligosacáridos ligados a lípidos. Los oligosacáridos anormales resistentes a la endoglucosidasa H en las células mutantes indican un defecto en la formación de precursores de glicoproteínas.
Área de la Ciencia:
- La bioquímica es la bioquímica.
- Biología Molecular Biología Molecular
- Biología celular Biología celular.
Sus antecedentes:
- Thy-1 es una glicoproteína de la superficie celular involucrada en las interacciones célula-célula.
- La glicosilación es una modificación post-traduccional crítica que afecta la función de las proteínas.
- Grupo de complementación Clase E Los linfomas Thy-1-mutantes presentan un defecto específico de glucosilación.
Objetivo del estudio:
- Para identificar el defecto específico de glucosilación en los linfomas tipo E Thy-1-mutantes.
- Para caracterizar los oligosacáridos ligados a lípidos (LLOs) en estas células mutantes.
- Para determinar el origen de oligosacáridos anormales encontrados en polipéptidos recién sintetizados.
Principales métodos:
- Aislamiento y caracterización de LLOs de células de linfoma de tipo salvaje y mutantes de Thy-1.
- Análisis de LLOs utilizando la digestión de la endoglucosidasa H.
- Análisis de oligosacáridos en polipéptidos recién sintetizados a partir de células mutantes.
Principales resultados:
- Se aislaron dos LLOs principales de células mutantes, ambos más pequeños que los LLOs de tipo salvaje.
- Los LLOs mutantes eran resistentes a la digestión de la endoglucosidasa H, a diferencia de los LLOs de tipo salvaje.
- Los oligosacáridos en los polipéptidos recién sintetizados en células mutantes también fueron resistentes a la endoglucosidasa H.
Conclusiones:
- El defecto de glicosilación en los linfomas de clase E Thy-1 es un bloqueo en la síntesis de precursores de LLO.
- Los LLOs anormales, resistentes a la endoglucosidasa H, se forman en células mutantes.
- Estos LLOs anormales son la fuente probable de los oligosacáridos resistentes a la endoglucosidasa H en las glicoproteínas de las células mutantes.
Más Videos Relacionados
Videos de Conceptos Relacionados
Glucose Transporters
15.2K
Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
15.2K
Diabetes Mellitus: Introduction
24
Diabetes mellitus consists of chronic metabolic disorders characterized by persistent hyperglycemia. This elevated blood glucose results from defects in insulin secretion, impaired insulin action, or both. Insulin, produced by pancreatic β-cells, is essential for maintaining glucose homeostasis by facilitating cellular glucose uptake for energy or storage. Disruptions in insulin production or function lead to glucose accumulation in the bloodstream, causing the clinical features and...
24
Type I Diabetes I: Introduction
45
Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1...
45
Type I Diabetes III: Clinical Manifestations
26
Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the...
26
Type II Diabetes I: Introduction
17
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
17
Hyperglycemia
25
Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose...
25

